Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced business updates and reported financial results for the first quarter ended March 31,
ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.
Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to ...
Centra announced Thursday it would welcome back an oncology doctor who previously spent eight years with the Alan B. Pearson ...
CGON stock results show that CG Oncology missed analyst estimates for earnings per share the first quarter of 2024.More From ...
James “Jim” Wallis and Patricia “Pat” Wallis pledged $500,000 to create the James and Patricia Wallis Professorship in ...
Novartis agreed to buy US biotech Mariana Oncology Inc. to strengthen its pipeline of drugs that can specifically target ...
Community oncology practices face challenges in attracting oncology fellows, highlighting the need for more fellows to ensure long-term sustainability.
Jessica McDade, B.S.N., RN, OCN, explains how she helps make her patients’ experience “a little less daunting” during their ...
The latest commissioned report by state Treasurer Dale Folwell — released Wednesday — determined North Carolina hospitals are ...
CG Oncology, Inc. released positive results from cretostimogene study for high-risk BCG-unresponsive bladder cancer patients.
Gritstone Oncology is reporting earnings from Q1 on May 9. Analysts expect Gritstone Oncology will report losses per share of $0.319. Go here to watch Gritstone Oncology stock price in real-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback